This information was used for design of a combinatorial therapeutic strategy of fenofibrate-mediated PPARα activation and siRNA-mediated HOTAIR repression to robustly retard glioma proliferation and invasion (Zhu et al. 2021). This evidence concerns the gene HOTAIR and central nervous system cancer.